tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Merck & Company (DE:6MK)
XETRA:6MK
Germany Market
6MK
Merck & Company
Overview
Analyst Forecasts
Dividends
Earnings
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Merck & Company (6MK) Stock News & Sentiment

Compare
66 Followers
Merck & Co.’s Strategic Positioning and Market Potential Justify Buy Rating Despite Challenges
Premium
Ratings
Merck & Co.’s Strategic Positioning and Market Potential Justify Buy Rating Despite Challenges
20h ago
MRK
Is MRNA Stock (MRNA) a Buy Ahead of Q2 Earnings?
Premium
Market News
Is MRNA Stock (MRNA) a Buy Ahead of Q2 Earnings?
22d ago
GSK
MRK
Merck & Company: Buy Rating Amid Promising New Product Cycle and Strategic Optimization
Premium
Ratings
Merck & Company: Buy Rating Amid Promising New Product Cycle and Strategic Optimization
23d ago
MRK
Merck’s Undervalued Pipeline and Strategic Prospects Drive Buy Rating Amid Market Challenges
Premium
Ratings
Merck’s Undervalued Pipeline and Strategic Prospects Drive Buy Rating Amid Market Challenges
23d ago
MRK
Merck & Co. Hold Rating: Balancing Gardasil Weakness and Keytruda Growth Amid Restructuring Efforts
Premium
Ratings
Merck & Co. Hold Rating: Balancing Gardasil Weakness and Keytruda Growth Amid Restructuring Efforts
24d ago
MRK
Options Volatility and Implied Earnings Moves Today, July 30, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, July 30, 2025
24d ago
F
ARM
Merck Reports Q2 2025 Financial Results and Strategic Initiatives
Premium
Company Announcements
Merck Reports Q2 2025 Financial Results and Strategic Initiatives
24d ago
MRK
More DE:6MK News >

6MK News on the Web

ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth
Zacks
Neutral
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
Zacks
Neutral
MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer
Zacks
Neutral
Pfizer Oncology Drugs Drive Sales in Q2: Will the Trend Continue?
Zacks
Neutral
Can Keytruda Sustain Merck's Growth Through the Rest of 2025?
Zacks
Neutral
GILD Stock Up 7% Post Q2 Earnings: Should You Buy Now or Wait?
Zacks
Neutral
Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan
rttnews
Neutral
2 Top Dividend Stocks to Buy on the Dip
The Motley Fool
Neutral

News Score - Last 7 Days

Neutral
DE:6MK
Sector Average
Media Buzz
This Week10 articles
Weekly Average17.75 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:6MK’s Media Buzz Sentiment?
10 articles about DE:6MK were published this week. In an average week, 17.75 articles are published.
    What is DE:6MK’s weekly average amount of articles?
    In an average week, 17.75 articles about DE:6MK are published.
      What is DE:6MK’s News Sentiment?
      50% of articles about DE:6MK were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        VKTXViking Therapeutics
        BWAYBrainsway
        RGTLFArgent Biopharma
        PAHCPhibro Animal Health
        MLYSMineralys Therapeutics, Inc.
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing